Ikarian Capital, LLC Zai Lab LTD Call Options Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 13, 2022	BUY	$27.77 - $64.4 $1.21 Million - $2.8 Million	43,500 Added 453.13%	53,100 $2.34 Million
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $527,040 - $1.01 Million	9,600 New	9,600 $603,000
Q3 2021 Nov 15, 2021	SELL	$105.0 - $178.37 $168,000 - $285,392	-1,600 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $200,176 - $288,000	1,600 New	1,600 $284,000

125

49.6M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.72B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.